Immix Biopharma's stock rockets after pediatric cancer treatment granted RPD by the FDAMarket Watch • 01/03/22
U.S. Food and Drug Administration Approves Immix Biopharma Rare Pediatric Disease Designation for IMX-110 as a Treatment for Life-Threatening Pediatric Cancer in ChildrenGlobeNewsWire • 01/03/22